Key facts
- This page summarizes Corebridge DECO II, LLC's Form 4 filing for Fractyl Health, Inc. (GUTS).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2024, 16:51.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Conversion of derivative security
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Conversion of derivative security
Conversion of derivative security
Additional SEC filing notes
Section 16 status
Corebridge DECO II, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date.
Footnote F2
Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc.